Publication Author: Sullivan_Sean

• Expenditures and health status among adults with back and neck problems.

  Martin BI, Deyo RA, Mirza SK, Turner JA, Comstock BA, Hollingworth W, Sullivan SD. Expenditures and health status among adults with back and neck problems. JAMA. 2008 Feb 13;299(6):656-64. doi: 10.1001/jama.299.6.656. Erratum in: JAMA. 2008 Jun 11;299(22)

  rakerr2

  February 13, 2008

• Outcomes for COPD pharmacological trials: from lung function to biomarkers.

  Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, Brusasco V, Burge PS, Calverley PM, Celli BR, Jones PW, Mahler DA, Make B, Miravitlles M, Page CP, Palange P, Parr D, Pistolesi M, Rennard SI, Rutten-van Mölken MP, Stockley R, Sullivan S

  rakerr2

  February 1, 2008

• Implementing an Ambulatory e-Prescribing System: Strategies Employed and Lessons Learned to Minimize Unintended Consequences.

  Devine EB, Wilson-Norton JL, Lawless NM, Hansen RN, Hollingworth W, Fisk AW, Sullivan SD. Implementing an Ambulatory e-Prescribing System: Strategies Employed and Lessons Learned to Minimize Unintended Consequences. In: Henriksen K, Battles JB, Keyes MA,

  rakerr2

  January 8, 2008

• Clinical and demographic characteristics help explain variations in pain at the end of life.

  Strassels SA, Blough DK, Veenstra DL, Hazlet TK, Sullivan SD. Clinical and demographic characteristics help explain variations in pain at the end of life. J Pain Symptom Manage. 2008 Jan;35(1):10-9. Epub 2007 Oct 23.

  rakerr2

  January 1, 2008

• Cost-effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding, and nonoperative weight loss interventions.

  Salem L, Devlin A, Sullivan SD, Flum DR. Cost-effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding, and nonoperative weight loss interventions. Surg Obes Relat Dis. 2008 Jan-Feb;4(1):26-32. Epub 2007 Dec 19.

  rakerr2

  January 1, 2008

• Global strategy for asthma management and prevention: GINA executive summary.

  Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O’Byrne P, Pedersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008 J

  rakerr2

  January 1, 2008

• Revisiting the cost-effectiveness of omalizumab.

  Campbell JD, Spackman DE, Sullivan SD. Revisiting the cost-effectiveness of omalizumab. Allergy. 2007 Dec;62(12):1469.

  rakerr2

  December 1, 2007

• Cost effectiveness of entecavir versus lamivudine with adefovir salvage in HBeAg-positive chronic hepatitis B.

  Veenstra DL, Sullivan SD, Clarke L, Iloeje UH, Tafesse E, Di Bisceglie A, Kowdley KV, Gish RG. Cost effectiveness of entecavir versus lamivudine with adefovir salvage in HBeAg-positive chronic hepatitis B. Pharmacoeconomics. 2007;25(11):963-77.

  rakerr2

  November 1, 2007

• The impact of e-prescribing on prescriber and staff time in ambulatory care clinics: a time motion study.

  Hollingworth W, Devine EB, Hansen RN, Lawless NM, Comstock BA, Wilson-Norton JL, Tharp KL, Sullivan SD. The impact of e-prescribing on prescriber and staff time in ambulatory care clinics: a time motion study. J Am Med Inform Assoc. 2007 Nov-Dec;14(6):722

  rakerr2

  November 1, 2007

• Cost-effectiveness of peginterferon alpha-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan.

  Sullivan SD, Veenstra DL, Chen PJ, Chang TT, Chuang WL, Tsai C, Patel K. Cost-effectiveness of peginterferon alpha-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan. J Gastroenterol Hepatol.

  rakerr2

  September 1, 2007